| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/14/2000 | WO2000053596A2 Imidazole compounds as histamine h3 ligands |
| 09/14/2000 | WO2000053595A1 Pyrimidine compounds |
| 09/14/2000 | WO2000053583A1 Inhibitors of protein tyrosine phosphatase |
| 09/14/2000 | WO2000053582A1 HETEROCYCLIC COMPOUNDS HAVING EFFECT OF ACTIVATING NICOTINIC ACETYLCHOLINE α4β2 RECEPTOR |
| 09/14/2000 | WO2000053572A1 Biphenyl derivatives as antagonists of the neurokinine-1 receptor |
| 09/14/2000 | WO2000053566A1 Crystalline hydrated dihydroxy open-acid simvastatin calcium salt |
| 09/14/2000 | WO2000053541A1 A vital matter and a producing method |
| 09/14/2000 | WO2000053236A2 Methods and compositions for targeted drug delivery |
| 09/14/2000 | WO2000053232A1 Matriptase, a serine protease and its applications |
| 09/14/2000 | WO2000053223A1 Apoptosis inducing molecule ii and methods of use |
| 09/14/2000 | WO2000053194A1 Remedies for joint diseases |
| 09/14/2000 | WO2000053178A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 09/14/2000 | WO2000053173A1 Dihydroxy open-acid and salts of hmg-co-a reductase inhibitors |
| 09/14/2000 | WO2000053169A2 Method of inhibiting a chaperone protein |
| 09/14/2000 | WO2000037422A3 Ion channel modulating agents |
| 09/14/2000 | WO2000037068B1 Use of a 5ht2a and 5ht2a/c receptor antagonist for preparing medicines for treating snoring and high resistance syndrome of upper anatomical airways |
| 09/14/2000 | WO2000037065A3 Endocrine therapy for breast cancer: combined treatment with tamoxifen plus alkyl pcdfs |
| 09/14/2000 | WO2000031263A3 Gtpase associated proteins |
| 09/14/2000 | WO2000030668A8 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration |
| 09/14/2000 | WO2000024717A3 Isoquinoline derivatives |
| 09/14/2000 | WO2000022129A9 Non-endogenous, constitutively activated human g protein-coupled receptors |
| 09/14/2000 | WO2000022125A9 6-protein-coupled receptor-like proteins, polynucleotides encoded by them, and methods of using same |
| 09/14/2000 | WO2000013709A3 Methods of treating osteoarthritis with inducible nitric oxide synthase inhibitors |
| 09/14/2000 | WO2000004012A8 COMPOUNDS SPECIFIC FOR THE HUMAN α1d ADRENERGIC RECEPTOR AND USES THEREOF |
| 09/14/2000 | WO2000003978A3 2,5-substituted benzolsulfonylureas and thioureas, methods for the production thereof, use thereof and pharmaceutical preparations containing the same |
| 09/14/2000 | WO1999066875A3 Combined preparation of anti-infectiously active compounds which inhibit the 2-c-methylerythrose-4 metabolic pathway, and inhibitors of lipid metabolism |
| 09/14/2000 | WO1999063999A8 H1-histamine receptor antagonists |
| 09/14/2000 | WO1999033836A9 3'-epimeric k-252a derivatives |
| 09/14/2000 | DE19911684A1 Human nucleic acid sequences from endothelial cells useful for treatment of angiogenic disease, including psoriasis, arthritis and diabetic retinopathy, etc |
| 09/14/2000 | CA2367315A1 Apoptosis inducing molecule ii and methods of use |
| 09/14/2000 | CA2367113A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| 09/14/2000 | CA2367108A1 Method of inhibiting a chaperone protein |
| 09/14/2000 | CA2366668A1 Pyrimidine compounds |
| 09/14/2000 | CA2366644A1 Tyrosine kinase inhibitors |
| 09/14/2000 | CA2366642A1 Carbamoyl tetrahydropyridine derivatives |
| 09/14/2000 | CA2366602A1 Pyridoxal analogues for vitamin b-6 disorders |
| 09/14/2000 | CA2366308A1 Inhibitors of protein tyrosine phosphatase |
| 09/14/2000 | CA2366260A1 Heterocyclic compounds having effect of activating .alpha.4.beta.2 nicotinic acetylcholine receptors |
| 09/14/2000 | CA2365869A1 Crystalline hydrated dihydroxy open-acid simvastatin calcium salt |
| 09/14/2000 | CA2365354A1 Methods and compositions for targeted drug delivery |
| 09/14/2000 | CA2364253A1 Dihydroxy open-acid and salts of hmg-co-a reductase inhibitors |
| 09/14/2000 | CA2362670A1 Matriptase, a serine protease and its applications |
| 09/14/2000 | CA2362319A1 Imidazole compounds as histamine h3 ligands |
| 09/13/2000 | EP1035115A1 4-Phenylpyridine derivatives and their use as NK-1 receptor antagonists |
| 09/13/2000 | EP1034793A1 Preventives/remedies for glaucoma |
| 09/13/2000 | EP1034301A1 Inhibition of an fgf-binding protein using ribozymes |
| 09/13/2000 | EP1034273A1 Histamine and serotonin binding molecules |
| 09/13/2000 | EP1034272A1 A cDNA ENCODING C6 $g(b)-CHEMOKINE LEUKOTACTIN-1(Lkn-1) ISOLATED FROM HUMAN |
| 09/13/2000 | EP1034184A2 Nuclear receptor ligands and ligand binding domains |
| 09/13/2000 | EP1034176A1 Thiophene-sulfonamide compounds |
| 09/13/2000 | EP1034171A1 Pseudopolymorphic forms of 2-[2-[4-[bis(4-fluorophenyl)methyl1]-1-piperazinyl]ethoxy]acetic acid dihydrochloride |
| 09/13/2000 | EP1034170A1 2-substituted 1,2-benzisothiazole derivatives and their use as serotonin antagonists (5-ht1a, 5-ht1b and 5-ht1d) |
| 09/13/2000 | EP1034164A1 Substituted beta-alanine derivatives as cell adhesion inhibitors |
| 09/13/2000 | EP1034163A1 New cysteine derivatives, processes for their production, and pharmaceuticals containing them |
| 09/13/2000 | EP1034004A1 Recombinant mycoplasma hyopneumoniae vaccine |
| 09/13/2000 | EP1034002A1 Method for inhibiting premature rupture of fetal membranes, ripening of uterine cervix and preterm labor |
| 09/13/2000 | EP1034001A1 Cd154 blockade therapy for therapeutic protein inhibitor syndrome |
| 09/13/2000 | EP1033998A1 Method of suppressing beta-amyloid-related changes in alzheimer's disease |
| 09/13/2000 | EP1033997A1 Method of mobilizing hematopoietic stem cells |
| 09/13/2000 | EP1033994A1 Methods of preparation of bioginkgo |
| 09/13/2000 | EP1033989A1 Method for reducing mast cell mediated allergic reactions |
| 09/13/2000 | EP1033983A1 Cyclic amino acid derivatives as cell adhesion inhibitors |
| 09/13/2000 | EP1033981A1 Formulations and methods for reducing toxicity of antineoplastic agents |
| 09/13/2000 | EP1033979A2 Cyp2a enzymes and their use in therapeutic and diagnostic methods |
| 09/13/2000 | EP1033978A1 Transdermal therapeutic system which contains a d2 agonist and which is provided for treating parkinsonism, and a method for the production thereof |
| 09/13/2000 | EP1033974A1 High drug load immediate and modified release oral dosage formulations and processes for their manufacture |
| 09/13/2000 | EP1033947A1 Non-steroidal anti-inflammatory agents inhibition of fibrotic response to an implanted device |
| 09/13/2000 | EP0983248A4 Analogs of duocarmycin and cc-1065 |
| 09/13/2000 | EP0975617A4 Inhibitors of cholesterol esterase |
| 09/13/2000 | EP0871611B1 New derivatives of glycylanilides, preparation and therapeutical application |
| 09/13/2000 | EP0817787A4 Nitrogenous macrocyclic compounds |
| 09/13/2000 | EP0763017B1 N-(3-amino-2-hydroxybutyl)sulphonamide derivatives as hiv protease inhibitors |
| 09/13/2000 | EP0723439B1 Combination of progesterone antagonists and anti-oestrogens with partial agonistic action for use in hormone-replacement therapy for peri- and post-menopausal women |
| 09/13/2000 | EP0586570B1 Backbone modified oligonucleotide analogues |
| 09/13/2000 | CN1266433A Benzpyrido cycloheptane compounds useful for inhibition of franesyl protein transferase |
| 09/13/2000 | CN1266432A Bispyrido-cyclohepatne compounds useful for inhibition of farnesyl protein transferase |
| 09/13/2000 | CN1266431A Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists |
| 09/13/2000 | CN1266429A Novel pentaerythrite derivatives, the production and use thereof and intermediate products for the synthesis of the same |
| 09/13/2000 | CN1266428A Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
| 09/13/2000 | CN1266427A New amidino derivatives and their use as thrombin inhibitors |
| 09/13/2000 | CN1266423A 1-amino-alkylcyclohexane NMDA receptor antagonists |
| 09/13/2000 | CN1266057A Novel cyano-indole serotonin reextracted inhibitor compound, its preparation process and medicinal compositions having same |
| 09/13/2000 | CN1266054A Aryl carboxylic acid and tetrazole derivant |
| 09/13/2000 | CN1265921A Erythropoiesis for treating anemia of family and raised animals |
| 09/13/2000 | CN1265915A Health-care product soluble granules made of 24 Chinese medicinal and making method thereof |
| 09/13/2000 | CN1265904A Traditional Chinese medicinal pill with function of prolonging life |
| 09/13/2000 | CN1265881A Shampoo compositions |
| 09/13/2000 | CN1056374C Tricyclic diazepine vasopression antagonists |
| 09/13/2000 | CN1056312C Medicine for treating carsickness and method for preparing same |
| 09/12/2000 | US6118045 Mammal having transgene with promoter and enhancer from same mammary gland specific gene, signal sequence for mammary secretory cells, and recombinant dna coding for acid alpha glucosidase; processed/secreted enzyme for pompe's disease |
| 09/12/2000 | US6118017 Substituted-(3-cyclopentyloxy-4-methoxyphenyl)-3-phenylcyanocyclobutan-1-one |
| 09/12/2000 | US6118001 Anticancer agent; antiarthritic agent |
| 09/12/2000 | US6117970 Sodium salt of [poly-(2,5-dihydroxyphenylene)]-4-thiosulphuric acid of linear structure as regulator of cell metabolism and production method thereof |
| 09/12/2000 | US6117912 Sublingual and buccal administration of selegiline for treating certain selegiline-responsive diseases and conditions |
| 09/12/2000 | US6117902 6,8-dimercaptooctanoic acid derivatives substituted at the 6-S and/or 8-S position with the (3-methylthiopropanoyl) radical and pharmaceutical compositions intended for the treatment of cancerous tumors |
| 09/12/2000 | US6117898 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase |
| 09/12/2000 | US6117888 Thrombin inhibitors |
| 09/12/2000 | US6117883 Useful for modulating a muscarinic receptor. |
| 09/12/2000 | US6117882 5-HT4 agonists and antagonists |
| 09/12/2000 | US6117881 N-cinnamoyl derivatives of (β) carbolines |